James S. Hanson's Insider Trades & SAST Disclosures

James S. Hanson's most recent trade in G1 Therapeutics Inc was a trade of 35,700 Stock Options (Right to buy) done . Disclosure was reported to the exchange on Jan. 3, 2023.

Share

Note

This is a custom search result for pattern James S. Hanson.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
G1 Therapeutics Inc 52 week high	James S. Hanson	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	35,700	35,700	-		-	Stock Options (Right to buy)
G1 Therapeutics Inc 52 week high	James S. Hanson	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	17,900	43,455 (0%)	0%		0	Common Stock
G1 Therapeutics Inc 52 week high	James S. Hanson	General Counsel	Sale of securities on an exchange or to another person at price $ 5.58 per share.	03 Jan 2023	1,639	41,816 (0%)	0%	5.6	9,138	Common Stock
G1 Therapeutics Inc 52 week high	James S. Hanson	General Counsel	Sale of securities on an exchange or to another person at price $ 5.41 per share.	03 Jan 2023	729	41,087 (0%)	0%	5.4	3,942	Common Stock
G1 Therapeutics Inc 52 week high	James S. Hanson	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2022	53,000	53,000	-		-	Stock Options (Right to buy)
G1 Therapeutics Inc 52 week high	James S. Hanson	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2022	12,000	27,000 (0%)	0%		0	Common Stock
G1 Therapeutics Inc 52 week high	James S. Hanson	General Counsel	Sale of securities on an exchange or to another person at price $ 10.61 per share.	03 Jan 2022	1,445	25,555 (0%)	0%	10.6	15,334	Common Stock
G1 Therapeutics Inc 52 week high	James S. Hanson	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jan 2021	58,000	58,000	-		-	Stock Options (Right to Buy)
G1 Therapeutics Inc 52 week high	James S. Hanson	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jan 2021	11,000	15,000 (0%)	0%		0	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades